gimli
SYNGENE stock analysis context
SYNGENE INTERNATIONAL Stock Context for AI Screening
SYNGENE INTERNATIONAL LTD is a small-cap stock in Healthcare. This page summarizes key screening signals for SYNGENE INTERNATIONAL, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about SYNGENEPrice
₹461.85
1M return
+5.94%
3M return
+4.33%
Market cap
₹18,554.91 cr
PE
44.59
ROE
+9.26%
RSI
53.35
Turnover
₹22.02 cr
Why it can matter in screens
- Momentum: SYNGENE is above 50DMA; RSI is 53.35.
- Returns: 1M +5.94%, 3M +4.33%, 6M -26.60%.
- Liquidity: latest turnover is ₹22.02 cr.
- Valuation: PE 44.59, PB n/a, ROE +9.26%, ROCE +11.84%.
- Growth: 3Y sales CAGR +11.90%, 3Y profit CAGR +7.83%.
Try these prompts
- Analyze SYNGENE INTERNATIONAL with valuation, momentum and industry peers
- Compare SYNGENE with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare SYNGENE with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.